TaiRx, Inc. (TPEX:6580)
Taiwan · Delayed Price · Currency is TWD 27.50
-0.30 (-1.08%)
Sep 26, 2025, 3:00 PM CST
TaiRx Market Cap
TaiRx has a market cap or net worth of 3.04 billion as of September 29, 2025. Its market cap has decreased by -19.50% in one year.
Market Cap
3.04B
Enterprise Value
2.62B
Revenue
15.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.50
Market Cap Chart
Since June 20, 2017, TaiRx's market cap has decreased from 3.25B to 3.04B, a decrease of -6.35%. That is a compound annual growth rate of -0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 3.04B | 6.70% |
| Dec 31, 2024 | 2.85B | 17.14% |
| Dec 29, 2023 | 2.44B | -27.90% |
| Dec 30, 2022 | 3.38B | -29.76% |
| Dec 30, 2021 | 4.81B | 86.51% |
| Dec 31, 2020 | 2.58B | 119.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 286.16B |
| PharmaEssentia | 189.36B |
| Bora Pharmaceuticals Co., LTD. | 84.40B |
| Lotus Pharmaceutical | 67.06B |
| Lumosa Therapeutics | 48.18B |
| Oneness Biotech | 32.14B |
| Polaris Group | 28.58B |
| Center Laboratories | 27.60B |